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Abstract
Cyclin-dependent kinase 5 (Cdk5) is a proline-directed serine/threonine kinase that has been implicated in learning, synaptic
plasticity, neurotransmission, and numerous neurological disorders. We previously showed that conditional loss of Cdk5 in
adult mice enhanced hippocampal learning and plasticity via modulation of calpain-mediated N-methyl-D-aspartic acid
receptor (NMDAR) degradation. In the present study, we characterize the enhanced synaptic plasticity and examine the
effects of long-term Cdk5 loss on hippocampal excitability in adult mice. Field excitatory post-synaptic potentials (fEPSPs)
from the Schaffer collateral CA1 subregion of the hippocampus (SC/CA1) reveal that loss of Cdk5 altered theta burst
topography and enhanced post-tetanic potentiation. Since Cdk5 governs NMDAR NR2B subunit levels, we investigated the
effects of long-term Cdk5 knockout on hippocampal neuronal excitability by measuring NMDAR-mediated fEPSP
magnitudes and population-spike thresholds. Long-term loss of Cdk5 led to increased Mg
2+-sensitive potentials and a lower
threshold for epileptiform activity and seizures. Biochemical analyses were performed to better understand the role of Cdk5
in seizures. Induced-seizures in wild-type animals led to elevated amounts of p25, the Cdk5-activating cofactor. Long-term,
but not acute, loss of Cdk5 led to decreased p25 levels, suggesting that Cdk5/p25 may be activated as a homeostatic
mechanism to attenuate epileptiform activity. These findings indicate that Cdk5 regulates synaptic plasticity, controls
neuronal and behavioral stimulus-induced excitability and may be a novel pharmacological target for cognitive and
anticonvulsant therapies.
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Introduction
Cyclin-dependent kinase 5 (Cdk5), a proline-directed serine/
threonine protein kinase, and its neuronal-specific activating
cofactors have been implicated in numerous physiological and
pathological processes in the mammalian nervous system [1–14].
Cdk5 has been implicated in hippocampal learning and synaptic
plasticity [5,7,10,15–17] and the pathogenesis of neurodegenera-
tive disorders, such as Alzheimer’s disease and neuropsychiatric
illnesses, such as addiction [2,15,18,19].
We previously reported that Cdk5 controls hippocampus-
dependent learning and synaptic plasticity [7]. Conditional loss
of Cdk5 improved performance in several hippocampal learning
tasks and reduced the threshold for LTP induction. The
enhancement in synaptic plasticity was due to increased
NMDAR-mediated currents secondary to elevated surface expres-
sion of NR2B. Cdk5 was shown to facilitate the calpain-mediated
degradation of NR2B upon activation of NMDARs. The
regulation of NMDAR degradation appears to play a critical role
in synaptic plasticity [20].
Our initial study revealed a number of positive effects that
resulted from conditional loss of Cdk5 in the brains of adult
mice [7,15]. Inducible loss of Cdk5 in adult mice improved
learning and increased NMDAR-mediated synaptic plasticity (2–
4 weeks after knockout) [7,15]. Here, we report the effects of
adult, conditional Cdk5 loss on the induction of synaptic
plasticity and hippocampal and stimulation-induced behavioral
excitability. Since the loss of Cdk5 enhanced plasticity via
increased NMDAR-mediated currents, we examined NMDAR-
mediated field excitatory postsynaptic potential (fEPSP) magni-
tudes and population-spike thresholds in knockout (KO) and
control (WT) mice. Although enhanced hippocampal plasticity is
associated with increased learning we hypothesized that synaptic
plasticity associated with loss of Cdk5 would also lead to
increased hippocampal epileptiform activity and seizure suscep-
tibility.
PLoS ONE | www.plosone.org 1 June 2009 | Volume 4 | Issue 6 | e5808Results
Conditional knockout of Cdk5
To circumvent the neonatal lethality of the constitutive Cdk5
KO mice and non-specificity of pharmacological inhibitors
[11,21–23], conditional KO of Cdk5 was achieved by deriving
mice in which loxP elements flanked critical exons in both Cdk5
alleles. Recombination was mediated with a transgenic estrogen
receptor-Cre recombinase fusion, under control of the prion
promoter [24] in response to a 15-day regimen of hydroxytamox-
ifen as previously described [7]. Hydroxytamoxifen-dosed wild-
type littermate mice served as controls (WT).
Altered theta burst synaptic response accompanies
enhanced LTP after conditional knockout of Cdk5
LTP was induced in hippocampi from Cdk5 WT and KO
animals within the SC/CA1 pathway on a 64-channel multielec-
trode array (Figure 1A). As expected, Cdk5 KO mice displayed a
reduced threshold for LTP induction (Figure 1B) [7]. To
determine if this enhancement was due to increased responsiveness
during the theta burst stimulation (TBS) used to induce LTP we
examined the fEPSPs during TBS. In WT slices, theta bursts
briefly led to facilitation followed by moderate depression. In
contrast, in KO slices, a TBS produced an immediate depression
and subsequent larger magnitude depression compared to controls
(Figure 1C). The 10 ms inter-stimulus interval produced a
8.166.3% facilitation in WT slices, but in KO slices we observed a
12.964.7% depression (Figure 1C; Burst 1, EPSP 2). Interest-
ingly, this significant and notable discrepancy between WT and
KO mice was specific for the shortest intervals of 10 ms (100 Hz).
Paired-pulse potentiation at inter-stimulus intervals (ISI) between
25 and 800 ms (40–1.25 Hz) were not significantly different [9].
Repolarization after a theta burst stimulus is, in part, dependent
on Ca
2+-activated K
+-channels [25]. To evaluate for possible
aberrations in Ca
2+-activated K
+-channels, burst duration and
repolarization were examined. Analysis revealed no differences
between KO and WT in both burst duration and rebound during
theta burst stimuli.
Responses to CA1 hippocampal tetanic stimuli in WT and
Cdk5 KO mice
To further evaluate synaptic plasticity in WT versus Cdk5 KO
mice, responses to high and low frequency tetani were measured.
The fEPSP amplitudes were measured during a 100-Hz high
frequency tetanus in the presence of NMDAR antagonism. As
with the TBS in Figure 1, this experiment revealed a paired-pulse
disparity between KO and WT (Figure 2A). Because this
experiment was performed in the presence of a NMDAR-
antagonist, the enhanced depression was not due to NMDA
activation. After the 2
nd pulse, Cdk5 KO and WT mice displayed
similar responses to 100-Hz tetani (Figure 2A). The fEPSPs
during low frequency tetani are often measured to assess the status
of the presynaptic reserve vesicle pool. A 14 Hz train in the
presence of a NMDAR antagonist elicited equivalent fEPSP
facilitation followed by vesicle depletion and fEPSP depression in
both groups (Figure 2B). In the presence of NMDA antagonism
these data show no detectable aberration in the presynaptic
reserve vesicle pool due to Cdk5 loss.
Conditional loss of Cdk5 leads to an enhancement in CA1
hippocampal post-tetanic potentiation
After a high frequency tetanus, neurons exhibit a form of short-
term plasticity called post-tetanic potentiation (PTP). Although
much of this phenomenon remains uncharacterized, PTP is likely
due to a tetanus-induced elevation in presynaptic Ca
2+ which leads
to a short-lived increase in vesicle release [26]. Changes in PTP
could result from alterations in presynaptic Ca
2+ channel
properties or the size of the readily releasable pool of vesicles.
Conditional loss of Cdk5 led to an enhancement in PTP following
a either a 100 Hz tetanus (Figure 2C) or TBS [7]. In the presence
of a NMDAR antagonist, a 100 Hz tetanus produced
120.764.3% and 142.469.7% PTP in WT and KO slices,
respectively. These findings indicate that loss of Cdk5 enhances
NMDA-independent short-term plasticity.
Conditional loss of Cdk5 leads to elevated Mg
2+-sensitive
potentials
In addition to their role in LTP induction, NMDARs play key
roles in many intracellular signaling cascades, neuronal excitability
as well as seizure generation [27]. Consequently, in vitro slice
physiology epileptiform activity is often measured in Mg
2+-free
conditions [28,29]. Since loss of Cdk5 led to a NMDAR-mediated
enhancement in synaptic plasticity, we analyzed Mg
2+-sensitive
potentials in Cdk5 KO mice, thus allowing measurement of
fEPSPs containing a predominant NMDA component. Mg
2+-
sensitive evoked fEPSP measurements were taken within the SC/
CA1 hippocampal pathway. The removal of NMDA receptor
Mg
2+-blockade produced a 1.71-fold larger fEPSP amplitude
change in KO than WT (148.967.6 vs. 128.664.7% of baseline,
respectively; Figure 3A, left). There was also greater overall
charge transfer in Cdk5 KO mice versus controls as measured by
fEPSP areas (162.364.4 vs. 145.265.7% of baseline, respectively;
Figure 3A, right). These findings indicate that loss of Cdk5 led to
increased Mg
2+-sensitive post-synaptic potentials suggesting in-
creased NMDAR function.
Chronic loss of Cdk5 reduced threshold for epileptiform
population-spike activity
Hippocampal NMDAR activation is an important step in many
in vitro and vivo seizure models [27]. Abnormal neuronal excitability
may produce epileptiform-like activity in acute brain slices.
Hyperexcitability can be characterized by an increased propensity
for populations of cells to fire in synchrony generating, so called,
population spikes. We examined whether conditional loss of Cdk5
increased susceptibility to in vitro epileptiform activity in the SC/
CA1 pathway after unmasking NMDARs. Synaptically-evoked
fEPSPs in the stratum pyramidale were measured in Mg
2+-free
conditions. Stimulation of the SC/CA1 pathway at 20%-maximal
stimulation intensity produced population spikes in 3.762.5% of
WT and 10.465.0% of KO slices. A stronger 50%-maximal
stimulation intensity produced population spikes in 89.664.0% of
KOslicesbutonly16.7467.7%ofWT slices(Figure3B). Stronger
stimulation intensities elicited population spikes in greater number
and larger magnitude in both KO and WT slices. These results
suggest show that loss of Cdk5 reduces the threshold to induce
evoked epileptiform activity in hippocampal slices.
Aberrations in Na
+ channel properties can affect neuronal
excitability [30–33] and Na
+ channel antagonists serve as a
therapeutic anticonvulsants. Basal population-spike thresholds are
dependent on Na
+ channel activation. Therefore, we surveyed the
basal in vitro population-spike threshold and the effects of partial
Na
+ channel blockade on fEPSPs. To analyze population spike
threshold, input/output measurements were collected in the strata
radiatum and pyramidale. The stimulation thresholds to induce
population spikes in both layers were equivalent between groups.
Furthermore, partial blockade (.50%) of Na
+ channels with
Cdk5 KO Increases Excitability
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fEPSP amplitudes in KO and WT groups (Figure 4A). Loss of
Cdk5 lowered the threshold for population spikes and this could
not be rescued by substantial reduction (.50%) in Na
+ channel
availability [34].
Although the increase in NMDAR-mediated current in Cdk5
KO mice [7] likely contributes to the neuronal hyperexcitability,
additional mechanisms are also possible. Statistical analysis of
basal synaptic responses in the SC/CA1 stratum radiatum layer in
Mg
+-containing conditions revealed that Cdk5 KO mice, 2–4
Figure 1. Altered theta burst topography in SC/CA1 pathway accompanies enhanced LTP in Cdk5 KO mice. A, An acute hippocampal
slice resting on MED-64 multi-electrode array. fEPSPs were recorded (blue) after stimulation of the SC/CA1 pathway (red). B, LTP after a ten-burst
theta stimulus in representative WT and KO slices plotted as percent amplitude of baseline (210 to 0 min). C, Effects of Cdk5 KO on theta-burst
responses. Representative theta burst traces were extracted from LTP experiment illustrated in B, Quantitation plotted as percentage change in
amplitude (relative to the 1st fEPSP) of the 2
nd,3
rd, and 4
th field EPSP within a single stimulus train of 4 pulses at 100 Hz in control and KO slices. The
measures are shown for bursts 1–4 of a train. Similar results were obtained with slope calculations, n=5–8. *P,0.05 vs. WT; post hoc t-test. Data
represent mean6s.e.m.
doi:10.1371/journal.pone.0005808.g001
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compared to WT mice (7.760.4 vs. 6.360.4 ms, respectively;
Figure 4B). This increase in fEPSP duration likely represents an
impairment in repolarization and may contribute to increased
neuronal excitability. Antagonism of NMDARs, Ca
2+ channels,
and Na
+ channels did not reverse the elevated fEPSP half-width in
Cdk5 KOs (not shown). Impairments in inhibitory signaling could
result in behavioral hyperexcitability [27,35,36]. Therefore, the
effects of GABAA channel antagonists on fEPSPs were measured.
Administration of SR95531 led to equivalent increases in fEPSP
amplitudes in WT and KO (20.165.2 vs. 25.1612.1% increase
from baseline, respectively; Figure 4C, left). However, SR95531
decreased the fEPSP half-width in WT but not KO slices
(212.865.9% vs. +5.961.7% change, respectively; Figure 4C
right). These results suggest that GABAA-mediated signaling in
Cdk5 KO mice may compensate for the increased fEPSP
duration.
Increased behavioral seizure susceptibility follows
chronic loss of Cdk5
Although NMDARs are critical for synaptic plasticity and
learning, too much NMDAR activity may be harmful [37].
During our studies, we found that prolonged loss of Cdk5 was
associated with handling induced seizures and lethality when
compared with controls. This observation prompted quantitative
assessment of susceptibilities to handling-, pharmacologically-, and
audiogenically-induced seizures. Hydroxytamoxifen-dosed Cre
negative mice (WT) and vehicle-dosed animals carrying the Cre
transgene alone displayed no spontaneous, handling-induced, or
audiogenically-induced seizures. Furthermore, pharmacologically-
induced behavioral seizure susceptibilities and latencies were
equivalent between the vehicle-dosed and WT groups (not shown).
On the other hand, chronic loss of Cdk5 led to handling-induced
head nodding, wet dog shakes, or clonus behavioral seizures in
80% of mice after 8 weeks of Cdk5 KO (Figure 5A, top; Table 1).
While mild handling induced Racine scale 1–3 class seizures, more
stressful conditions, such as water immersion, triggered Racine
scale 3–5 seizures, tonus and death in additional cohorts of chronic
KO mice. Interestingly, increased seizure susceptibility correlated
with lethality as loss of Cdk5 for 8 weeks and daily handling
resulted in 40% mortality (Figure 5A, bottom; Table 1). In
summary, chronic loss of Cdk5 led to increases susceptibility to
handling-induced behavioral seizures and increases lethality.
To evaluate and quantify seizure susceptibility in Cdk5 KO
mice, seizure latencies were scored after animals were treated with
a convulsant, pilocarpine. Cdk5 KO mice displayed increased
susceptibility (Table 1) and significantly shorter latencies than
WT to undergo wet dog shakes (5.460.6 vs. 17.364.3 min,
respectively), clonus (9.063.0 vs. 19.364.8 min), and rearing and
falling (12.5361.9 vs. 37.0612.3 min; Figure 5B). Hence, Cdk5
KO led to 68.7%, 53.7%, and 66.2% decreases in mean latencies
to induce wet dog shakes, clonus, and rearing and falling
behavioral seizures. Chronic loss of Cdk5 led to increase central
nervous system excitability exhibited by the decreased threshold
for chemically-induced seizures.
Cranial electronencephalographic (EEG) electrodes and elec-
tromyographic (EMG) electrodes were implanted into mice and
spontaneous activity was recorded for characterization of electro-
graphic activity in WT versus Cdk5 KO mice. After loss of Cdk5
for 8 weeks, KO mice displayed epochs of multiple bursts (at 3–
4 Hz) of spike waves which correlated with tremor activity on
EMG (Figure 5C–D). Post- and inter-ictally, there were normal
EEG/EMG activities during wakefulness and sleep (Figure 5E–
F). Seizure activity was not observed in littermate hydroxytamox-
ifen-dosed WT controls (Figure S1). In summary, loss of Cdk5 for
2 months led to increased lethality, elevated seizure susceptibility,
and electrographic evidence of seizure activity.
Figure2. Tetanic stimulation and post-tetanic potentiation after
conditional loss of Cdk5. A, fEPSPs during high frequency
tetanus. fEPSPs amplitudes during 100 Hz tetani are plotted relative to
the 1
st response in the presence of 75 mM AP5. Asterisk indicates that the
2
nd fEPSP during the train was significantly different between WT and KO
(P,0.05, student’s t-test). B, Effects of Cdk5 KO on fEPSPs during low
frequency tetanus. fEPSPs amplitudes during 14 Hz tetani are plotted
relative to the 1
st response in the presence of 75 mMA P 5 .C, Post-tetanic
potentiation after a 100 Hz stimulus. Representative traces and fEPSP
amplitudes were measured and plotted relative to baseline (75 mMA P 5 ,
n=5–8; P,0.05, student’s t-test). Data represent mean6s.e.m.
doi:10.1371/journal.pone.0005808.g002
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As an additional study of behavioral excitability, the brainstem
primary acoustic startle circuit was examined by measuring
acoustic startle reactivity. Animals were exposed to auditory
stimuli (white noise) at various decibels and startle responses were
measured. Cdk5 KO startle responses were 1.860.6-, 2.260.5-,
2.560.4-, and 2.360.6-fold larger than WT after 90, 100, 110,
and 120 db pulses, respectively (Figure 6A). No differences
between WT and KO were observed in habituation of startle
responses (Figure 6B) or pre-pulse acoustic inhibition
(Figure 6C). Thus, loss of Cdk5 in the adult brain elevated the
acoustic startle responses but had no detectable difference on
short-term acoustic habituation or pre-pulse inhibition.
Audiogenic behavioral seizures after chronic loss of Cdk5
Audiogenic stimulation rarely produces seizures in healthy wild
types animals. However, in special animal breeds, after kindling,
or with certain genetic modifications, high-frequency acoustic
tones can produce behavioral and electrographic seizure activity.
While chemically-induced seizures are generally thought to model
seizures of hippocampal or temporal lobe origin, audiogenic
seizures may originate in the brainstem [29]. Given that loss of
Cdk5 led to increases in acoustic startle reactivity, we examined
whether loss of Cdk5 reduced the susceptibility to audiogenic
seizures. Short-term loss of Cdk5 (2–4 weeks) did not increase
susceptibility to audiogenic behavioral seizures (0/10 short-term
Cdk5 KO animals exhibited behavioral seizure activity). In
contrast, prolonged loss of Cdk5 (for 8 weeks) increased
susceptibility to audiogenically-induced seizures. High frequency
audiogenic stimulation had no effect on WT but induced wild
running in 37% of KO mice in 32.3 sec (Table 2). Wild running
progressed to tonic-clonic seizures and tonus followed by death in
18% of KO animals within 56.0 sec. Consequently, chronic loss of
Cdk5 in the adult brain increased the propensity towards
acoustically-induced behavioral seizures.
Status epilepticus and electroconvulsive shock leads to
the production of Cdk5-activating cofactor in the
hippocampus
Both conditional KO of Cdk5 [7] and transient overexpression
of p25 [5] result in increased synaptic plasticity and learning.
There may be common mechanistic features between loss of Cdk5
and diversion of Cdk5 to form a complex with p25. Interestingly,
human hippocampal sclerosis is accompanied by p25 generation
and altered Cdk5 activity [38]. To further assess the role of Cdk5
in acute seizures and the homeostasis of neuronal excitability,
Figure 3. Increased Mg
2+-sensitive post-synaptic potential and reduced threshold for epileptiform activity after conditional loss of
Cdk5. A, Representative traces and quantitation of fEPSP amplitude (n=12) and area (n=6) in the stratum radiatum relative to baseline following
Mg
2+ wash-out. B, Representative traces and quantitation showing reduced threshold for population spikes in the stratum pyramidale of KO slices
after stimulation in the hippocampal SC/CA1 pathway in Mg
2+-free conditions. Quantitation shows % of slices displaying population spikes at
indicated stimulation intensities (% of maximum). Recordings were performed 4–6 weeks post-KO. n=16–18; ANOVA revealed a main effect of
genotype (F1,217=36.16, p,0.0001), stimulation (F6,217=115.41, p,0.0001) and interaction between genotype and stimulation (F6,217=11.76,
p,0.0001). **P,0.05, *P,0.01,
{P=0.067 vs. WT, post hoc t-test. Data represent mean6s.e.m.
doi:10.1371/journal.pone.0005808.g003
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p25 levels were assessed in hippocampal lysates. Kainate-induced
status epilepticus led to 5.062.7- and 3.961.3-fold increases in
p25 level and p25/p35 ratio, respectively (Figure 7A, left).
Similarly, pilocarpine-induced status epilepticus caused 2.860.8-
and 2.560.6-fold increases in p25 level and p25/p35 ratio
(Figure 7A, right). Hence, chemically-induced status epilepticus
in normal WT animals caused p25 levels in increase in
hippocampal lysates.
Chemically-induced acute seizures only represents one of many
models used to study seizures. Generation of p25 was also
analyzed following electrical electroconvulsive shock. Electrocon-
vulsive shock, which causes broad forebrain epileptiform activity,
is clinically used to treat depression [39] and experimentally used
for the generation of seizures [40]. Acute electroconvulsive shock
resulted in time-dependent accumulation in p25 in hippocampus
(Figure 7B). Sixty minutes following electroconvulsive shock, p25
levels increased 2.4760.08-fold. The findings suggest that both
pharmacologically- and electrically-induced epileptiform activity
results in accumulation of the Cdk5 activating cofactor, p25.
Chronic but not acute loss of Cdk5 leads to reduced
levels of Cdk5-activating cofactor in the hippocampus
Studies implicating Cdk5 and p25 in neuronal excitability
suggest that Cdk5 may be activated in order to either attenuate or
modulate excitability during seizures. Since Cdk5 KO mice
displayed elevated neuronal excitability and susceptibility to
seizures, we examined the levels of p25 in Cdk5 KO mice.
Hippocampi from subacute Cdk5 KO mice (2–4 weeks after KO)
contained similar levels of p25 compared with controls
(111.7613.7% of WT, p=0.6). However, chronic loss of Cdk5
for 6–8 weeks led to a 58.4612.4% reduction in basal levels of p25
(Figure 7C). Consequently, chronic but not acute loss of Cdk5
leads to reduced levels of p25. The decrease in p25 levels
corresponds to an increase in neuronal excitability and seizure
susceptibility.
Figure 4. GABAA-mediated signaling partially compensates for increased fEPSP half-width in Cdk5 KO mice. A, Effect of partial Na
+-
channel blockade on fEPSP amplitude. Representative fEPSPs traces from WT (red) and KO (black) are shown before and after TTX treatment (n=12).
B, Increased basal fEPSP half-width in SC/CA1 pathway of KO hippocampus. Representative fEPSPs traces from WT (red) and KO (black) are shown
with quantitation (n=9–10). C, Representative fEPSPs traces before and after GABAA blockade (top) are shown with quantitation (bottom).
Histograms show the changes in amplitude and half-width following treatment with 2 mM SR95531 (n=7). 1 and 2 indicate traces before and after
treatment with SR95531, respectively. SR95531 had similar effects on fEPSP slope measurement. *P,0.05 vs. WT; post hoc t-test.
doi:10.1371/journal.pone.0005808.g004
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PLoS ONE | www.plosone.org 6 June 2009 | Volume 4 | Issue 6 | e5808Figure 5. Elevated seizure susceptibility after chronic conditional Cdk5 loss. A, Kaplan-Meier seizure morbidity and survival curves. Percent
of animals observed to have handling-induced seizures and percent survival are plotted against weeks post-KO; n=10–14; the differences for
morbidity and mortality were statistically significant, P,0.01, log-rank test. B, Latency to pilocarpine-induced wet-dog shakes (WDS), clonus (Cl), and
rearing/falling (RF) seizures in mice, 8 weeks post-KO (n=7–10). *P,0.05 vs. WT, Student’s t-test. Data represent means6s.e.m. C–F, Representative
spontaneous EEG/EMG recordings from a conditional KO mouse, 8 weeks post-KO. C, Appearance of multiple bursts (at 3–4 Hz) of spike waves which
were frequently clustered as shown and accompanied by evident tremor and clonic seizures. D, Expanded view of 10 sec of the recording period
shown in Figure C, displaying two spike bursts separated by about 2 sec. E, Post-ictally, there was rapid return to normal EEG/EMG and resumption of
ongoing activity as displayed here during a period of wakefulness. F, Expanded view of 10 sec of the recording period shown in Figure E, Calibration
1 sec and 50 mV; the recording periods shown in panels D and F are annotated by the 10 sec bars in C and E respectively.
doi:10.1371/journal.pone.0005808.g005
Table 1. Long-term conditional Cdk5 knockout increases susceptibility to seizures.
Category of seizures genotype Morbidity Seizure latency (wks
1) Mortality
2
Handling-induced WT 0% (0/12) n/a 0% (0/12)
KO 80% (8/10) 5.6360.53 40% (4/10)
Category of seizures genotype Clonus Status epilepticus Tonus & Death
Chemically-induced
3 WT 71% (5/7) 57% (4/7) 42% (3/7)
KO 100% (7/7) 100% (7/7) 86% (6/7)
1Weeks after last dose of hydroxytamoxifen.
2Within 8 wks.
3325 mg/kg pilocarpine, i.p./2.5 mg/kg scopolamine, s.c.
doi:10.1371/journal.pone.0005808.t001
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PLoS ONE | www.plosone.org 7 June 2009 | Volume 4 | Issue 6 | e5808Figure 6. Increased acoustic startle reactivity with normal short-term acoustic habituation and prepulse inhibition in Cdk5 KO mice.
A, Acoustic startle reactivity in Cdk5 KO mice (4–8 weeks post-KO, n=17–19). ANOVA revealed a main effect of genotype (F1,204=16.35, p,0.0001),
decibels (F5,204=19.67, p,0.0001) and interaction between genotype and decibels (F5,204=3.72, p=0.003). *P,0.01, **P,0.001,
{P=0.08 vs. WT, post
hoc t-test. B, Habituation to a 120 db sound is shown as startle reactivity in three consecutive time blocks. ANOVA revealed effects of genotype
(F1,68=8.62, p,0.006) and trial (F2,68=14.65, p,0.0001) but no interaction between genotype and trial (F2,68=0.31, p=0.7326). n=17–19. C, Prepulse
inhibition in Cdk5 KO mice. Prepulse at indicated decibels were given 5 ms prior to a 120 db sound. Prepulse inhibition is represented as percent
decrease compared to an isolated 120 db sound. ANOVA revealed effect of decibel (F2,32=143.74, p,0.0001) but no effect of genotype (F1,32=2.03,
p=0.1735) or interaction (F2,32=0.78, p=0.469). n=8–10. Vehicle-treated animals behaved similarly to WT. Data represent mean6s.e.m.
doi:10.1371/journal.pone.0005808.g006
Table 2. Audiogenic seizures after long-term conditional Cdk5 knockout
1.
Genotype Wild Running Tonic-clonic seizure Tonus/death
Morbidity Latency (s) Morbidity Latency (s) Morbidity Latency (s)
WT 0% (0/10) n/a 0% (0/10) n/a 0% (0/10) n/a
KO 27% (3/11) 32.366.7 18% (2/11) 50.0611.0 18% (2/11) 56.066.0
1After exposure to 90 db, 2.8 kHz pulse tone for 3 min
doi:10.1371/journal.pone.0005808.t002
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Previous studies have implicated Cdk5 in the regulation of
neuronal excitability [1]. Cdk5 has been suggested to both increase
[41,42] and decrease [43] neurotransmitter release and modulate
striatal neuron excitability [1]. Cdk5 has specifically been
implicated in exocytosis and endocytosis via phosphorylation of
numerous substrates including synapsin, amphiphysin I, dynamin,
and others [44–47]. We previously demonstrated that conditional
loss of Cdk5 led to enhancements in plasticity and learning via
modulation of NMDAR degradation [9]. Furthermore, transient
overexpression of Cdk5-activating cofactor, p25, increases
NMDAR-mediated plasticity and synaptic transmission [7,15].
Here, we further characterize the enhancement of hippocampal
plasticity in Cdk5 KO mice by studying fEPSPs during theta bursts
and tetanic stimuli. We first show that within the SC/CA1
pathway, Cdk5 KO mice displayed altered LTP-inducing TBS
topography. During the detailed LTP analyses, we find that loss of
Cdk5 also leads to an NMDAR-independent enhancement in
PTP, a presynaptic form of short-term plasticity. Although Cdk5
KO had no effect on paired pulse facilitation (PPF) with
interstimulus intervals between 25 and 800 [7], Cdk5 KO did
lead to depression with a shorter 10 ms inter-stimulus interval.
Cdk5 may theoretically confer these changes by increasing the
number of presynaptic vesicles, increasing presynaptic Ca
2+-influx,
or increasing sensitivity to presynaptic Ca
2+. Changes in
probability of presynaptic vesicle release are usually accompanied
by broad impairments in PPF. However, since loss of Cdk5 only
conferred a PPF deficit at a very short interstimulus interval,
additional information is necessary to better elucidate Cdk59s role
in the presynapse. Although several studies implicate Cdk5 in
vesicle release and recycling [41–43,48], the exact nature of
Cdk59s role in the presynaptic compartment is still unclear. Future
studies examining Cdk59s role in presynaptic terminal would be
beneficial.
Conditional loss of Cdk5 initially leads to enhanced learning,
plasticity and increased NMDAR-mediated currents [7]. In the
present study, electrophysiological extracellular hippocampal
recordings in vitro reveal that conditional loss of Cdk5 also leads
to elevations in fEPSPs with a predominant NMDA component
and reduced threshold for population-spike activity. It is known
that the NR2B NMDAR subunit directly modulates neuronal
excitability and contributes to seizures [49–52], so it is possible
that a similar mechanism is involved following loss of Cdk5. Other
mechanisms may also contribute to the enhanced hippocampal
excitability. For example, loss of Cdk5 led to a subtle impairment
in fEPSP repolarization in the hippocampal SC/CA1 pathway.
Nonetheless, the data suggests that Cdk5 functions to attenuate
hippocampal neuronal excitability via several mechanisms includ-
ing the modulation of NMDARs.
Over time, Cdk5 KO mice displayed an increase in seizure
susceptibility, suggesting a progressive increase in excitability.
Chronic loss of Cdk5 increased the propensity for pharmacolog-
ically- and audiogenically-induced seizures. The reduced threshold
for behavioral seizure activity correlated with EEG/EMG
evidence of spontaneous seizures. Given the complexity, impact,
and significance of spontaneous seizure activity, additional EEG
recordings over an extended period of are warranted in future
studies. In addition, conditional Cdk5 KO mice also displayed an
increase in behavioral startle reactivity. We also found an
Figure 7. p25 generation in the hippocampus after pharmacologically-induced status epilepticus and electroconvulsive shock. A,
Representative immunoblots (top) and quantitation of p25 per tubulin (middle) and p25/35 ratio (bottom) after treatment with kainate and
pilocarpine. VEH=saline; KA=kainate (50 mg/kg); SC=scopolamine (2 mg/kg)/saline; and SC/PI=scopolamine (2 mg/kg)/pilocarpine (280 mg/kg).
n=4; *P,0.05 vs. VEH and SC in; Student’s t-test. B, Representative immunoblots of p25 and quantitation of p25/p35 ratio 15, 30, and 60 min
following electroconvulsive shock administration compared to unshocked controls (time=0); n=2. C, Hippocampal p25:p35 ratio 6–8 weeks post-KO.
Crude lysates were immunoblotted for p25 and p35. Double asterisk indicates P,0.05 versus aged WT, Student’s t-test; n=3–4. Data represent
means6s.e.m.
doi:10.1371/journal.pone.0005808.g007
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Cdk5 KO mice: after 10 weeks of Cdk5 KO, the majority of Cdk5
KO mice displayed signs of increased behavioral excitability and
propensity towards handling-induced seizures. Up to 40% of
affected mice died soon after displaying seizure activity.
The electrophysiological and behavioral experiments reveal
similar trends. Initially, Cdk5 KO mice display increased
NMDAR-mediated currents, enhanced plasticity, and impaired
neuronal repolarization. Later, mice exhibit increased startle
reactivity and reduced threshold for in vitro population spikes.
Then, mice exhibit spontaneous electrographic seizures, handling-
induced seizures, audiogenic seizures and lower threshold for
pharmacologically-induced seizures. Although the experiments
were performed at varying time-points after Cdk5 KO, together,
the results suggest that loss of Cdk5 leads to a progressive increase
in neuronal and behavioral excitability, ultimately leading to
seizures.
Abnormal expression and dysregulation of Cdk5 and its
cofactors have been demonstrated in tissues from human cortical
dysplasia [53] and hippocampal sclerosis [38,46,54]. KO of p35
leads to cortical lamination defects, seizures, and lethality [55–57].
Mice lacking p35 also display abnormal morphological and
functional organization of the hippocampus, dysplastic hippocam-
pi, heterotopic pyramidal cells, and granule cell dispersion and
may serve as a model for cortical dysplasia [29,57]. In this study
we show that chemically-induced status epilepticus and electro-
convulsive shock in healthy animals induced acute generation of a
Cdk5-activating cofactor, p25. Chronic loss of Cdk5 is associated
with both seizures and reduced levels of p25. These published and
new findings indicate that Cdk5 and its cofactors may play key
regulatory roles in neuronal excitability.
Recent data have demonstrated dual roles for both Cdk5 and its
activating cofactor, p25, in learning and plasticity [5,7]. A
dichotomy may also exist for Cdk5/p259s role in pathological
neuronal excitability associated with seizures. Loss of Cdk5
increases excitability and leads to seizures, which corresponds with
decreased levels of p25. Acute seizures in healthy animals and
chronic seizures in human epileptics produces elevated levels p25
[54]. During periods of increased Ca
2+-influx, neurons produce p25
followingcalpain activation [58]. Initially,Cdk5/p25 mayserve as a
homeostatic molecule to dampen excitatory transmission and
inhibit seizure activity. However, over-excitation could result in
excessive Ca
2+-influx and p25 generation, aberrant Cdk5 activity
and neurotoxicity [59]. Thus, Cdk5 may serve to inhibit abnormal
epileptiform activity when a neuron is in a normal state or promote
cell death following excess and non-physiological Ca
2+ influx. We
previously showed that Cdk5 facilitates calpain-mediated degrada-
tion of the NR2B NMDAR subunit [7]. Cdk5 KO may impair
calpain-mediated p25 generation and thereby disrupt normal
homeostatic mechanisms that prevent seizures. Future studies on
Cdk5, calpain, p25, and NR2B may better our understanding of the
divergent roles for Cdk5 in neuronal physiology and disease.
Current anticonvulsant therapeutics increase inhibitory neuro-
transmission, suppress high frequency neuronal firing by reducing
voltage-gated Na
+ channels availability, or inhibit voltage-gated T-
type Ca
2+-channels. Such therapeutic options produce unwanted
side effects, are only efficacious in 70% of adults suffering from
recurrent seizures [60], and generally alleviate the symptoms
rather than curing or modifying the underlying etiology [27].
Aberrations in neuronal excitability can produce abnormal
electrical discharges in the brain leading to seizure activity. Thus,
a better understanding of the cellular mechanisms underlying
neuronal excitability will aid in the development of novel
therapeutics for seizures.
In future studies, it will be worthwhile to directly assess whether
the increase in neuronal excitability following Cdk5 KO has any
affects on presynaptic transmission, neuronal fiber sprouting, cell
count, and cell survival. Furthermore, it would be interesting to
study how long-term loss of Cdk5 affects hippocampal plasticity
and learning. Although short-term loss of Cdk5 produced
enhancements in plasticity and learning [7], it is possible that
chronic loss of Cdk5 and the associated epileptiform activity leads
to neurodegeneration and impaired synaptogenesis, learning, and
structural plasticity [5,16].
Materials and Methods
Animals and reagents
All procedures have been conducted in accordance with
relevant NIH, national and international guidelines and were
approved by the UT Southwestern Institutional Animal Care and
Use Committees. Unless otherwise noted, mice were housed 4 per
cage in a colony maintained at 23uC with a 12 h light/dark cycle
(lights on from 7:00 A.M. to 7:00 P.M.) and ad libitum food and
water. Breeding, genotyping, and KO induction were performed
as previously described [7]. Adult mice were treated with 4-
hydroxytamoxifen for 15 days (66.67 mg per kg, i.p.). Post-KO
time period refers to the time following end of hydroxytamoxifen
treatment. Hydroxytamoxifen-dosed mice with floxed Cdk5 alleles
mice served as WT littermate controls, as previously reported [7].
As additional controls, electrophysiolgical and behavioral exper-
iments were also performed on genetic control strains: vehicle-
dosed and undosed mice with and without Cre transgene and floxed
Cdk5 alleles. All experiments were performed on adult male mice
with experimenter blind to genotype. Unless otherwise specified,
reagents were purchased from Sigma.
Electrophysiological recordings
Transverse hippocampal slices from 8–14 week old males were
prepared in cutting saline (200 mM sucrose, 3 mM KCl, 1.4 mM
NaH2PO4, 26 mM NaHCO3, 2 mM MgCl2, 2 mM CaCl2,
10 mM glucose) and maintained in an interface chamber
containing artificial cerebrospinal fluid [61,62]. Extracellular field
excitatory post-synpatic potentials (fEPSPs) in the Schaffer
Collateral/CA1 hippocampal pathway (SC/CA1) were synapti-
cally evoked at 0.033 Hz and recorded in the stratum pyramidale and
stratum radiatum layers using a 64-channel array (150 mm interpolar
distance, MED-P5155, Alpha MED Sciences). Input-output
measurements were performed as described [7] and, unless
otherwise stated, fEPSPs were evoked using a stimulation intensity
which elicited 50% maximal response. Data acquisition and
analysis were performed using the Multielectrode MED64
hardware and software packages (Panasonic) essentially as
described [7]. Stimulus artifacts were removed and additional
analyses were performed using custom macros running under Igor
Pro, Microsoft Excel, and Graphpad Prism. LTP experiments
were performed as described [7]. Theta burst topography was
assessed 2–4 weeks post Cdk5 KO as previously described [7,63].
fEPSP amplitudes in the stratum radiatum layer were measured with
respect to the first fEPSP within each theta burst.
Post-tetanic potentiation
Post-tetanic potentiation was assessed as previously described,
2–4 weeks post-KO [7]. Basal input/output measurements were
performed to determine stimulus intensity to elicit 40% of the
maximal fEPSP amplitude. Input/output analysis, paired-pulse
facilitation, and tetani were performed in the absence of any drugs
unless otherwise indicated. Post-tetanic potentiation (PTP) was
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brief 100 Hz tetanus [23] and post-tetanus recordings. PTP
measurements were made on the initial recording after the tetanus.
Measurements of fEPSP slope showed similar results.
fEPSP measurements in Mg
2+-free conditions and
epileptiform activity
Mg
2+-free fEPSP and epileptiform activity experiments were
performed 4–8 weeks post-KO. fEPSP input/output measure-
ments were made in regular ACSF to determine the stimulation
intensities required for 20% and 100% of maximal fEPSP
amplitudes. Baseline and Mg
2+-sensitive fEPSP amplitudes and
areas were measured in regular ACSF and Mg
2+-free ACSF,
respectively. Mg
2+-sensitive fEPSP measurements in the stratum
radiatum were recorded using the 20%-maximal stimulation
intensity, which allowed for accurate measurement of fEPSP
magnitude in the absence of population spikes and epileptiform
activity. Any fEPSP measurements contaminated with population
spikes were excluded from calculations. Evoked population spikes
and epileptiform activity in the stratum pyramidale were recorded in
Mg
2+-free buffer. Input/output measurements were recorded in
Mg
2+-free buffer in triplicate and analyzed for population spikes.
Fiber volley amplitude versus stimulus intensity was not signifi-
cantly changed after washout of Mg
2+. Maximum stimulation
intensities were pre-determined by measuring the stimulus and
fiber volley magnitudes necessary produced the maximum fEPSP
magnitudes during basal input/output measurements. Stimulation
intensities were binned and data was fit with a sigmoidal curve
with R
2.95%.
Gross Na
+ channel function was assessed by calculating
population spike threshold and measuring the effect of partial
Na
+ channel blockade in normal ACSF. Traditional input/output
measurement were performed in regular Mg
2+-containing ACSF
and visually analyzed for presence of population spikes in stratum
radiatum and stratum pyramidale. Pecentage of slices displaying
population spikes versus fiber volley amplitude was plotted. After
input/output measurements, a stable baseline was recorded at
20%-maximal stimulation. fEPSP magnitudes were measured after
addition of 50 nM TTX. fEPSP amplitudes were plotted relative
to baseline.
fEPSP repolarization
Repolarization experiments were performed 2–4 weeks post-
KO. Half-width was measured as the duration of fEPSP at the
half-maximal amplitude in normal Mg
2+-containing ACSF. To
examine contributions of Na
+ channel, NMDAR, voltage-gated
Ca
2+ channel, GABAAR-mediated synaptic transmission on
fEPSP amplitudes, slopes, and half-widths, fEPSPs were measured
before and after treatment with 50 nM tetrodotoxin (TTX),
75 mM AP5, 0.1 or 0.5 mM NiCl, and 2 mM SR95531,
respectively.
Electronencephalographic (EEG)-Electromyographic
(EMG) recordings
Adult male mice were surgically implanted for long-term EEG/
EMG monitoring as previously described [64]. Mice were
anesthetized with a mixture containing 25 mg/ml ketamine and
2.5 mg/ml xylazine (administered i.p. at a dose of 0.1 mL/
mouse). They were then held in a stereotaxic frame fitted with a
mouse adaptor (David Kopf Instruments, Tujunga, CA). The
cranium was exposed, cleaned of all connective tissue, and 4 burr
holes were drilled, anterior and posterior to bregma, bilaterally
(AP 1.1, ML61.45 and AP 23.5, ML61.45). A prefabricated
implant, with 4 EEG and 2 EMG electrodes, was then
stereotaxically lowered and cemented to the skull using glass
ionomer dental cement (Ketac-Cem Aplicap; ESPE, Norristown,
PA). EMG wire electrodes were inserted contralaterally into the
nuchal musculature using blunt dissection techniques. After
suturing, the mouse was removed from the stereotaxic frame
and allowed to recover from anesthesia. This design for the EEG/
EMG implant allowed precise insertion of electrodes, targeting the
frontal and occipital cortices at a consistent depth, just touching
the dura, while minimizing surgical trauma.
EEG/EMG measurements were performed 8 weeks post-KO.
Mice were housed individually under a 12 h light-dark cycle at
2461uC, with standard laboratory chow (Harlan Teklad,
Madison, WI) and water being replenished as necessary each
day. Mice were not otherwise disturbed. They were habituated to
these conditions for a week before EEG/EMG signals were
recorded over 24 hour duration. Connections were made from the
implanted cranial electrodes to the amplifier (Grass Model 78;
Grass Instruments, West Warwick, RI) using a flexible, freely
moving, lightweight cable. Amplified and filtered (EEG: 0.3–
100 Hz; EMG: 30–300 Hz) signals were digitized at a sampling
rate of 250 Hz, displayed using custom polygraph software, and
archived for subsequent off-line analysis. Subsequently, the EEG/
EMG record was visually screened for seizure epochs.
Seizures and startle response behaviors
All behavioral experiments were performed with two groups of
8–14 week old males. The short-term KO group consisted of
animals 2–4 weeks after Cdk5 loss (i.e., 2–4 weeks following last
does of hydroxytamoxifen). The chronic KO group consisted of
animals 8 weeks following Cdk5 loss. Behavioral seizures were
scored based on the Racine scale [29,65,66]. Seizure classes one
through five were scored as mouth movements, head nodding or
wet dog shakes, clonus, rearing, and rearing/falling, respectively.
Behavioral seizure parameters such as wild running, tonic-clonic
seizures, and tonus were also scored. To assess handling-induced
seizures, animals which experienced daily handling were initially
observed for signs of spontaneous seizures in home cage for
30 min and then assessed for 30 min after tail lift and scruffing.
Handling-induced seizures typically included head nodding,
clonus, or clonus with loss of balance. Chemically induced seizures
were studied in mice 8-weeks post-KO. Animals were given
scopolamine (2.75 mg/kg, s.c.) 5 min prior to pilocarpine
(325 mg/kg, i.p.). Latency to and frequency of wet-dog shakes,
clonus, tonus, rearing and falling and other seizures classes were
recorded.
Startle response behaviors were studied 4–8 weeks post-KO
using the SR-Lab system (San Diego Instruments) as described
[23,67–69]. Audiogenic seizures were studied 2–4 weeks and 8
weeks post-KO and induced in a plexiglass shock box with clear
front and rear walls (MedAssociates). Mice were scored for
baseline behavior for 3 min and scored for seizure activity during
exposure to a 90 db, 2,800 Hz pulse tone for 3 min. Frequency of
and latency to wild running, tonic-clonic seizures, tonus, other
seizure stages, and death were recorded.
Pharmacologically-induced status epilepticus and
electroconvulsive shock
Six-week old C57BL/6 (Charles River Labs) wild-type mice
were injected with vehicle (saline, i.p.), kainate (50 mg/kg, i.p.;
Tocris), scopolamine (2 mg/kg, s.c.)/saline (i.p.), or scopolamine
(2 mg/kg, s.c.)/pilocarpine (280 mg/kg, i.p.). Scopolamine was
injected 5 min prior to pilocarpine. Animals were scored for
latencies to and frequencies of seizure stages including head
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rearing, and, rearing/falling. Hippocampi were dissected 25 min
after first robust episode of rearing/falling, flash frozen, and stored
at minus 80uC.
Electroconvulsive shock (ECS) was administered to adult male
Sprague–Dawley rats (175–200 g) by delivering a current of
50 mA for 0.3 sec via bilateral ear clips essentially as described
[70]. Hippocampi were dissected at the specified time-points after
stimulation, flash frozen, and stored at minus 80uC. Animals
which did not receive the shock served as controls.
Immunoblot analysis
Frozen samples were sonicated in boiling 1% SDS containing
50 mM NaF and boiled for an additional 5 min. Protein
concentrations were determined by the BCA protein assay (Pierce)
using bovine serum albumin standards. An equal amount of total
protein (100 mg) from each sample was subjected to SDS-PAGE
followed by electrophoretic transfer to nitrocellulose membranes
(Whatman). The membranes were immunoblotted using antibod-
ies for p35/p25 (1:200; C-19 Santa Cruz) and alpha-tubulin
(1:5000), followed by incubation with a horseradish peroxidase-
conjugated anti-rabbit or anti-mouse secondary antibody (1:8000;
Chemicon). Antibody binding was detected by autoradiography
using the enhanced chemiluminescence immunoblotting detection
system (Amersham Biosciences) and quantified by densitometry
using Image J software (NIH).
Statistical analysis
All data was represented at mean6s.e.m. Errors for fold
changes were calculated using standard error propagation rules.
Differences between data groups were evaluated for significance
using analysis of variance (ANOVA) with post hoc t-tests and
statistical significance was set to p,0.05.
Supporting Information
Figure S1 Representative EEG/EMG recordings from a wild-
type control mouse. A, A period of normal wakefulness. B,
Expanded view of 10 sec of the recording period shown in A.
Calibration 1 sec and 50 mV; the recording period shown in panel
B is annotated by the 10 sec bar in A.
Found at: doi:10.1371/journal.pone.0005808.s001 (0.19 MB TIF)
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